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Clusterin is an extracellular chaperone that specifically interacts with slowly 
aggregating proteins on their off-folding pathway 
Abstract 
Clusterin is an extracellular mammalian chaperone protein which inhibits stress-induced precipitation of 
many different proteins. The conformational state(s) of proteins that interact with clusterin and the 
stage(s) along the folding and off-folding (precipitation-bound) pathways where this interaction occurs 
were previously unknown. We investigated this by examining the interactions of clusterin with different 
structural forms of α-lactalbumin, γ-crystallin and lysozyme. When assessed by ELISA and native gel 
electrophoresis, clusterin did not bind to various stable, intermediately folded states of α-lactalbumin nor 
to the native form of this protein, but did bind to and inhibit the slow precipitation of reduced α-
lactalbumin. Reduction-induced changes in the conformation of α-lactalbumin, in the absence and 
presence of clusterin, were monitored by real-time 1H NMR spectroscopy. In the absence of clusterin, an 
intermediately folded form of α-lactalbumin, with some secondary structure but lacking tertiary structure, 
aggregated and precipitated. In the presence of clusterin, this form of α-lactalbumin was stabilised in a 
non-aggregated state, possibly via transient interactions with clusterin prior to complexation. Additional 
experiments demonstrated that clusterin potently inhibited the slow precipitation, but did not inhibit the 
rapid precipitation, of lysozyme and γ-crystallin induced by different stresses. These results suggest that 
clusterin interacts with and stabilises slowly aggregating proteins but is unable to stabilise rapidly 
aggregating proteins. Collectively, our results suggest that during its chaperone action, clusterin 
preferentially recognises partly folded protein intermediates that are slowly aggregating whilst venturing 
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Clusterin is an extracellular mammalian chaperone protein which inhibits stress-
induced precipitation of many different proteins. The conformational state(s) of 
proteins that interact with clusterin and the stage(s) along the folding and off-folding 
(precipitation-bound) pathways where this interaction occurs were previously 
unknown. We investigated this by examining the interactions of clusterin with a 
variety of different structural forms of -lactalbumin, -crystallin and lysozyme. 
When assessed by ELISA and native gel electrophoresis, clusterin did not bind to 
various stable, intermediately folded states of -lactalbumin nor to the native form of 
this protein, but did bind to and inhibit the slow precipitation of reduced -
lactalbumin. Reduction-induced changes in the conformation of -lactalbumin, in the 
absence and presence of clusterin, were monitored by real-time 1H NMR 
spectroscopy. In the absence of clusterin, an intermediately folded form of -
lactalbumin, with some secondary structure but lacking tertiary structure, aggregated 
and precipitated. In the presence of clusterin, this form of -lactalbumin was 
stabilised in a non-aggregated state, possibly via transient interactions with clusterin 
prior to complexation. Additional experiments demonstrated that clusterin potently 
inhibited the slow precipitation, but did not inhibit the rapid precipitation, of 
lysozyme and -crystallin induced by different stresses. These results suggest that 
clusterin interacts with and stabilises slowly aggregating proteins but is unable to 
stabilise rapidly aggregating proteins. Collectively, our results suggest that during its 
chaperone action, clusterin preferentially recognises partly folded protein 
intermediates that are slowly aggregating whilst venturing along their irreversible off-
folding pathway towards a precipitated protein.  
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3SS--lactalbumin: -lactalbumin with Cys6-Cys120 selectively reduced and 
carboxymethylated; DTT: dithiothreitol; GuHCl: guanidinium hydrochloride; HDC: 
1% heat-denatured casein dissolved in PBS; HMW: high-molecular-weight; PBS: 
phosphate-buffered saline; R-cam--lactalbumin: reduced and carboxyamidated -
lactalbumin; R-cm--lactalbumin: reduced and carboxymethylated -lactalbumin; 
sHsp: small heat-shock protein. 
 
 
1. INTRODUCTION  
 
Molecular chaperones are a diverse group of proteins that interact with unfolded or 
partly folded proteins to stabilise them, thereby preventing them from potentially 
aggregating and precipitating [1,2]. Molecular chaperones are involved in a variety of 
cellular tasks including protein folding, trafficking and general stabilisation. As a 
result of their stabilising ability, the expression of many molecular chaperones is 
upregulated in disease states that are associated with protein misfolding and 
precipitation, for example, Alzheimer’s, Creutzfeldt-Jakob and Parkinson’s diseases 
[3]. Intracellularly, the well-characterised chaperone proteins, Hsp40, Hsp60 and 
Hsp70 (DnaJ, GroEL and DnaK in E. coli), are intimately involved in regulating the 
correct folding of some proteins in the crowded environment of the cell [4]. Another 
class of intracellular molecular chaperones, the small heat-shock proteins (sHsps), are 
not directly involved in protein folding. Instead, they are the major proteins 
associated with stabilising other proteins under stress conditions (e.g. heat, oxidation, 
infection, etc.) to prevent their large-scale precipitation [5]. In this process, the partly 
folded, stressed protein interacts via predominantly hydrophobic interactions with the 
sHsp to form a complex. Subsequently, when cellular conditions return to normal, 
this protein may be refolded via interaction with Hsp70 coupled to ATP hydrolysis 




Recently, we described the sHsp-like chaperone ability of the ubiquitous extracellular 
mammalian protein, clusterin [7]. Our data indicate that clusterin shares many 
similarities with sHsps in its mode of interaction with stressed proteins: it is a very 
efficient chaperone; it forms, primarily via hydrophobic interactions, complexes (of 
high mass) with stressed proteins; and it has no inherent ability to refold stressed 
proteins after the removal of stress [7-9, unpublished data]. Furthermore, as has been 
shown for some of the sHSPs [5,6], we have demonstrated that stressed proteins 
complexed with clusterin are stabilised in a folding-competent state that can readily 
be recovered into a correctly folded form via an ATP-dependent interaction with 
Hsp70 [9]. The implication from this observation is that the stressed protein is bound 
to clusterin in a partly folded state that is readily accessible to molecular chaperones 
with refolding ability. 
 
Following synthesis, proteins traverse rapidly along their folding pathway from 
unfolded to folded (and hence active) conformations. In between these two extremes, 
proteins adopt a variety of partly folded intermediates or molten globule states (e.g. 
designated I1 and I2) with varying degrees of structure. Along this pathway, molecular 
chaperones such as Hsp40, Hsp60 and Hsp70 assist the folding of proteins into their 
correct conformation. The protein folding pathway is reversible and, under stress 
conditions, proteins unfold from their native conformation along the reverse of this 
pathway to adopt intermediately folded states. Being partly structured, these 
intermediates expose significant hydrophobicity to solution. It is then possible for 
them to deviate from the folding/unfolding pathway along an irreversible off-folding 
pathway, leading to aggregation and potentially precipitation. sHsps interact with 
proteins along this pathway [10,11]. The conformational state(s) of proteins that 
interact with clusterin and the stage(s) along these pathways where this interaction 
occurs were previously unknown. We used an approach similar to that taken with the 
sHsps [10] to investigate this by examining the interactions of clusterin with a variety 
of structured forms of -lactalbumin, -crystallin and lysozyme. 
 
-Lactalbumin is a small, monomeric milk protein (mass ~14 kDa) that has a bound 
calcium ion at the interface between its two domains [12]. It is possible to prepare 
chemically-modified, monomeric and stable states of -lactalbumin with varying 
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degrees of partly folded structure that have structural similarities to intermediates 
along the folding/unfolding pathway of -lactalbumin (Table 1) [13,14]. GroEL 
interacts with some of these stable -lactalbumin intermediates [15,16] but -
crystallin, a representative sHsp, does not [10]. The folding/unfolding pathway of -
lactalbumin, and the intermediates along it, have been well characterised [17]. 
Reduction of the four disulphide bonds of -lactalbumin with dithiothreitol (DTT) 
also leads to a partly structured intermediate (Table 1). However, this intermediate 
has significant exposed hydrophobicity and slowly aggregates and precipitates along 
the off-folding pathway [10,11]. -Lactalbumin is an extracellular protein and is 
therefore a potential protein target for clusterin during its chaperone action in vivo 
under stress conditions. Reduction is not a physiologically relevant extracellular 
stress in vivo. However, since the structures of -lactalbumin intermediates are well 
studied and understood, conclusions drawn from studies of their interactions with 
clusterin have implications for defining the conformational features of stressed 
proteins that act as chaperone substrates for clusterin in vivo.  
 
In this study, the interaction of clusterin with intermediately folded forms of -
lactalbumin was examined by ELISA, native gel electrophoresis and real-time 1H 
NMR spectroscopy. In addition, the interaction of clusterin with both slowly and 
rapidly precipitating forms of -crystallin and lysozyme was investigated. Overall, the 
results indicate that clusterin is like the sHsps in recognising only slowly aggregating, 






Bovine -lactalbumin (calcium-depleted), lysozyme, bovine serum albumin, 
ovotransferrin and dithiothreitol (DTT) were purchased from Sigma (Sydney, 
Australia). Deuterated 1,4-D,L-d10-DTT was obtained from Cambridge Isotopes 
Laboratories (MA, USA). -Crystallin was purified from bovine lenses by size 
exclusion chromatography using standard methods [18]. Three stable, partly folded 
derivatives of -lactalbumin were prepared by methods described in [13,14]: R-cam-
-lactalbumin with its four disulphide bonds reduced and subsequently blocked by 
carboxyamidation, R-cm--lactalbumin with its four disulphide bonds reduced and 
subsequently blocked by carboxymethylation, and 3SS--lactalbumin with Cys6-
Cys120 selectively reduced and blocked by carboxymethylation. Their correct masses 
were confirmed by electrospray ionisation mass spectrometry. Apo -lactalbumin 
was prepared by heating solutions of the native protein, containing 1.5 mM EDTA, 
for 1 h at 45 oC. Clusterin was prepared from human serum using immunoaffinity 
chromatography as described earlier [19]. Clusterin-specific monoclonal antibodies, 
G7, 41D and 78E, were as described [20]. Agarose was obtained from Promega 
(Sydney, Australia). All other chemicals were of reagent grade and were obtained 
from Ajax Chemicals (Sydney, Australia).  
 
ELISA  
The -lactalbumin derivatives (R-cam--lactalbumin, R-cm--lactalbumin, 3SS--
lactalbumin) at 1 mg/ml in 20 mM NaH2PO4, pH 7.2, were adsorbed onto ELISA 
trays for 1 h at 37 °C (45 °C for apo -lactalbumin). Native -lactalbumin was 
adsorbed to ELISA trays at 1 mg/ml in 20 mM NaH2PO4, pH 7.2, for 5 h at 37 °C. -
Lactalbumin was also adsorbed to ELISA trays during reduction-induced aggregation 
by incubating the protein (at 1 mg/ml) in 20 mM NaH2PO4, 0.1 M NaCl, pH 7.2, 
containing 20 mM DTT, in ELISA wells for 5 h at 37 oC. Lyzozyme (50 g/ml in 0.1 
M NaHCO3, pH 9.5) was adsorbed for 1 h at 37 °C and then reduced by incubation 
with 15 mM DTT in PBS for 1 h at 37 °C. Following these steps, the ELISA trays 
were blocked for 1 h at 37 °C with HDC (10 mM phosphate, 150 mM NaCl, 1% 
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(w/v) heat-denatured casein, 0.04% (w/v) thymol, pH 7.4). Subsequently, purified 
clusterin dissolved in HDC (at 10 g/ml or at concentrations indicated in Figures) 
was incubated in ELISA wells for 1 h at 37 oC. The wells were then repeatedly 
washed with PBS and clusterin bound to the adsorbed proteins was measured using 
(i) an equi-volume mixture of G7, 41D and 78E monoclonal antibody tissue culture 
supernatants, followed by (ii) horseradish peroxidase-conjugated sheep anti-mouse Ig 
antibody, as described previously [7]. The substrate used was o-phenylenediamine 
dihydrochloride (OPD; 2.5 mg/ml in 0.05 M citric acid, 0.1 M Na2HPO4, pH 5.0, 
containing 0.03% (v/v) H2O2). 
 
Native gel electrophoresis and blotting  
Solutions containing either -lactalbumin (at 5 mg/ml), clusterin (at 1 mg/ml) or 
mixtures of both (at the same respective concentrations) in 50 mM Na2HPO4, pH 7.0, 
were incubated for 5 h at 37 oC with or without the addition of 20 mM DTT. In 
addition, solutions containing -lactalbumin derivatives (at 0.67 mg/ml) or mixtures 
of these derivatives and clusterin (both at 0.67 mg/ml) in 50 mM Na2HPO4, pH 7.0, 
were incubated (without DTT) for 5 h at 37 oC. Precipitated protein was then 
removed by centrifugation for 1 min at 10,000 rpm in a benchtop microfuge. 2 l of 
loading buffer (0.01 % bromophenol blue, 20% (v/v) glycerol) was added to aliquots 
of the supernatant in each case (containing 10 g of total protein) before loading on to 
1% (w/v) agarose gels. Proteins were electrophoresed at 60 V for approximately 3 h 
using 40 mM Tris, 20 mM acetic acid, 1 mM EDTA, pH 8.0 as running buffer (the 
structures of the various forms of -lactalbumin tested are not affected by EDTA). 
Proteins were subsequently transferred to polyvinylidine difluoride membrane (MSI, 
Westborough, MA, USA) by capillary transfer. The membranes were stained with 
SuperStain (Pierce, Rockford, IL, USA) for approximately 5 min, destained (in 45% 
(v/v) methanol, 10% (v/v) glacial acetic acid) for approximately 20 min, and then 
scanned using a BioRad GS670 Imaging Densitometer.  
 
NMR spectroscopy   
Real-time one-dimensional 1H NMR spectra were acquired at 500 MHz on a Varian 
Inova-500 NMR spectrometer. A sweep width of 5500 Hz was used over 9000 data 
points with an acquisition time of 0.82 s per scan and a delay between scans of 1.0 s. 
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Sixteen scans were acquired per spectrum which, along with two dummy scans, gave 
a total time between successive spectra of approximately 33 s. Successive spectra 
were acquired following the addition of 30 l of a 0.4 M solution of d10-DTT to 0.6 
ml of 50 mM phosphate, 0.1 M NaCl, in D2O, pH 7.2 containing 3.0 mg/ml -
lactalbumin in the absence or presence of 0.7 mg/ml clusterin. Under the latter 
conditions, the precipitation from solution of reduced -lactalbumin was completely 
prevented by the formation of a solubilised, high-molecular-mass clusterin--
lactalbumin complex [7]. An exponential line broadening of 3 Hz was applied to all 
NMR spectra prior to Fourier transformation. 
 
The effect of clusterin on slow versus rapid stress-induced precipitation of -
crystallin and lysozyme 
The effects of clusterin on the slow precipitation from solution of -crystallin were 
determined by heating -crystallin (at 1 mg/ml in 50 mM Na2HPO4, pH 7.0) at 60 oC 
with or without 50 g/ml clusterin. Similar experiments were conducted in which 
lysozyme (250 g/ml) was incubated at 42 oC in the same buffer as above containing 
20 mM DTT, with or without 400 g/ml clusterin. The extent of protein precipitation 
in each case was measured as turbidity (light scattering) at 360 nm using a model 
8453 diode-array spectrophotometer (Hewlett-Packard GMBH, Germany). We have 
shown before that control proteins (eg ovalbumin) do not inhibit protein precipitation 
under these conditions [7]. In other experiments, the effects of clusterin on the rapid 
precipitation of the same two proteins was determined; in these cases, for each target 
protein, the mass ratio of clusterin:target was maintained at the same level as in the 
experiments measuring slow precipitation (-crystallin:clusterin = 20:1.0, 
lysozyme:clusterin = 1.0:1.6). -Crystallin (300 g) was incubated for 20 min in 20 l 
of denaturing buffer (50 mM Na2HPO4, pH 7.0, 6 M guanidine hydrochloride 
(GuHCl)). This solution was added to 10 l of PBS containing 15 g of clusterin or 
one of two control proteins (BSA or ovotransferrin) before, over approximately 1 
min, successively adding 10-20 l aliquots of 50 mM Na2HPO4, pH 7.0, to effect 
rapid protein precipitation. Similarly, 3 mg of lysozyme was incubated for 20 min in 
30 l of denaturing buffer before 1 l of this solution was added to 19 l of PBS 
containing 160 g of either clusterin, BSA or ovotransferrin. These mixtures were 
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then diluted 5-fold, over approximately 1 min, with subsequent additions of 10 l 
aliquots of 50 mM Na2HPO4, pH 7.0, to give a final volume of 100 l. For both 
proteins, the requirement for step-wise dilutions precluded kinetic analyses of the 
same type as that performed in the slow precipitation experiments. Experiments 
measuring rapid protein precipitation were performed in the wells of microplates and 
the end-point turbidity (representing the final level of protein precipitation) measured 
as light scattering at 360 nm with a Spectramax 250 microplate reader (Molecular 






ELISA and native gel electrophoretic analyses of the interaction of clusterin with 
various structural forms of -lactalbumin  
In ELISA, only negligible (probably non-specific) binding of clusterin to stable, 
intermediately folded or unfolded forms of -lactalbumin (see Table 1) or to the 
native form of the protein was detected (Figure 1A). In contrast, clusterin bound 
strongly to reduced -lactalbumin (Figure 1A), confirming our earlier report of this 
interaction [7]. The inability of clusterin to bind to the other structural forms of -
lactalbumin tested suggested that it is unable to complex with these forms in solution. 
This interpretation was confirmed by native gel electrophoretic analyses, in which 
pre-incubation with clusterin had no effect on the electrophoretic mobility of native 
-lactalbumin or its stable derivatives (Figure 1B). When clusterin was co-incubated 
with -lactalbumin prior to electrophoresis, two discrete bands corresponding to each 
of the individual proteins were detected (Figure 1B, lane 5). However, when these 
proteins were co-incubated with DTT under similar conditions, very much less 
protein was detected in the bands corresponding to the individual proteins and a 
single protein band of unique electrophoretic mobility, representing a clusterin--
lactalbumin complex [7], was detected (Figure 1B, compare lanes 5 and 6). In a 
previous study [7], reduced -lactalbumin was prepared in the same manner as this 
study. The precipitation of reduced -lactalbumin was prevented by the presence of a 
sufficient quantity of clusterin which resulted in the formation of a solubilized, high 
molecular mass -lactalbumin-clusterin complex, detected by size exclusion 
chromatography. SDS-PAGE was used to demonstrate that both proteins were present 
in this complex [7]. 
 
Real-time 1H NMR analysis of the interaction between clusterin and reduced -
lactalbumin 
Real-time 1H NMR spectra were acquired of reduced -lactalbumin in the absence 
and presence of sufficient clusterin to prevent the precipitation of reduced -
lactalbumin (a 4.3:1.0 w:w ratio of -lactalbumin:clusterin; [7]). Figures 2A & B 
show the aromatic region of selected NMR spectra of -lactalbumin without clusterin 
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or in the presence of clusterin at various times after the addition of DTT. Being a 
structured protein, -lactalbumin has a well-dispersed NMR spectrum, as is apparent 
from the spectrum acquired prior to the addition of DTT (at 0 s; Figure 2A). After the 
addition of DTT, successive spectra reflect the loss in structure of -lactalbumin as 
its four disulphide bonds were sequentially reduced (Figure 2A). The hyper-reactive 
disulphide bond between Cys6 and Cys120 is reduced very quickly (< 1 s) whereas 
the remaining disulphide bonds are reduced over a much longer timeframe [14]. In 
the absence of clusterin, as disulphide bond reduction occurred, the spectra changed 
from (i) the resolved NMR spectrum of the native species (at 0 s), to (ii) a broad 
spectrum with some dispersion, reflecting a partly folded intermediate containing 
most secondary and some tertiary structure (I1, e.g. at 384 s), to (iii) a broad spectrum 
lacking dispersion (I2, e.g. at 639 s), produced by an intermediate that has some 
secondary structure but that lacks any tertiary structure (Figure 2A). The broadness of 
both spectra reflects the dynamic nature of these intermediates that have 
indeterminate conformation. The spectrum of I2 has strong similarities to that of the 
partly folded intermediate of -lactalbumin observed at pH 2, the so-called molten 
globule “A-state” [10]. With time, this spectrum was lost as reduced -lactalbumin 
aggregated and precipitated.  
 
Spectra from the I2 state of -lactalbumin were completely lost after ~ 1,700 s in the 
absence of clusterin but, in the presence of clusterin, were still present 5400 s after 
the addition of DTT (Figure 2B). This suggests that clusterin stabilises the I2 state of 
-lactalbumin. Other than this difference, the real-time NMR spectra acquired 
following the addition of DTT to -lactalbumin, either in the absence or presence of 
clusterin, were generally similar in form (compare Figures 2A and 2B). The 
concentration of clusterin used was too small to give rise to significant resonances in 
the NMR spectrum. As for spectra acquired in the absence of clusterin, in the 
presence of clusterin the spectrum from the I2 state of -lactalbumin was gradually 
lost (Figure 2B). However, in this case, the loss of resonances was not due to the 
protein precipitating but very probably arose because, under these conditions, -
lactalbumin is known to complex with clusterin to produce species of large molecular 
mass [7] that would tumble slowly and give rise to very broad NMR spectra.  
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The resonance at 6.8 ppm in the spectrum of the I2 form arises from the (3,5) aromatic 
protons of the tyrosine residues of reduced -lactalbumin and is relatively isolated 
from the broad envelope of other aromatic resonances (Figures 2A & B) [10,11]. 
Conveniently, native -lactalbumin does not have a significant resonance at this 
chemical shift. Therefore, monitoring its intensity with time following addition of 
DTT provides a means of following the buildup and decay of this state without 
complications from resonance(s) arising from the native state of -lactalbumin. 
Figure 2C shows a plot of the intensity of this resonance versus time after addition of 
DTT for -lactalbumin in the absence and presence of clusterin. In both cases, the 
resonance intensity built up rapidly to a maximum at ~ 380 s, indicating that clusterin 
had no significant effect on the buildup of signal from the I2 state. Mass spectrometric 
and stopped flow UV studies have shown that the maximum NMR resonance 
intensity from the I2 state of -lactalbumin occurs when all four of its disulphide 
bonds are reduced (J.A. Carver, R.A. Lindner, C. Lyon, D. Canet, H. Hernandez, 
C.M. Dobson and C. Redfield, submitted for publication). Therefore, the data indicate 
that clusterin does not significantly affect the rate of reduction of disulphide bonds in 
-lactalbumin. After maximum resonance intensity was reached, the signal decayed 
as I2 either (i) aggregated (in the absence of clusterin), or (ii) complexed with 
clusterin (Figure 2C). As a means to compare the rates of decay of the 6.8 ppm 
resonance for -lactalbumin, the equation for a first–order process was fitted to the 
data shown in these figures. The resonance intensity decayed with time with apparent 
first-order rate constants of, in the absence of clusterin, (1.81 ± 0.09) x 10-3 s-1 and, in 
the presence of clusterin, (5.07 ± 0.13) x 10-4 s-1. Thus, under the conditions 
described, clusterin approximately tripled the lifetime of the I2 state of -lactalbumin, 
before complexing with it.  
 
Analysis of the interaction of clusterin with slowly and rapidly precipitating 
forms of -crystallin and lysozyme 
-Crystallin, a major lens protein, slowly aggregates and precipitates when exposed to 
elevated temperature [18]. Under the conditions tested (mass ratios of -
crystallin:clusterin = 20:1.0, and lysozyme:clusterin = 1.0:1.6), clusterin significantly 
inhibited the slow precipitation of (i) -crystallin, induced by heating at 60 oC (Figure 
3A), and (ii) lysozyme, induced by reduction at 42 oC (Figure 3B). Higher ratios of 
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clusterin:target gave dose-dependent increases in the inhibition of precipitation of 
either -crystallin or lysozyme (data not shown). When either -crystallin or lysozyme 
is unfolded in 6 M GuHCl and then diluted into phosphate buffer, they rapidly 
precipitate from solution. Using the same mass ratios of clusterin:target as in the 
experiments measuring slow protein precipitation, clusterin had no significant effect 
on the rapid precipitation of either -crystallin or lysozyme (Figures 3C and 3D). 
Furthermore, even when the clusterin:target ratios were doubled, clusterin still failed 




Clusterin is a heterodimer comprised of  and  subunits linked by five disulphide 
bonds that adopts an ill-defined heterogeneous aggregation state in aqueous solution. 
Size exclusion chromatographic analysis indicates that DTT does not cause physical 
dissociation of the  and  chains of clusterin [7]. Furthermore, the native gel 
electrophoretic mobilities for unreduced and reduced clusterin (lanes 1 and 2 in Fig. 
1B) are essentially identical, indicating that reduction does not induce any gross 
changes in clusterin structure. Furthermore, reduction does not abrogate the 
chaperone action of clusterin with a variety of target proteins [7,9]. Thus, reduced 
clusterin is a functionally active protein. 
 
From the results presented in Figure 1, it is apparent that clusterin does not bind to (i) 
native -lactalbumin, (ii) its stable, monomeric, partly structured derivatives, or (iii) 
the fully unfolded form of -lactalbumin. Previously, we also demonstrated that -
crystallin did not interact with these states of -lactalbumin [10]. However, clusterin 
does bind to the reduced (stressed) form of the protein (Figure 1, and [7]). CD spectra 
of reduced -lactalbumin show that it has some secondary structure but very little, if 
any, tertiary structure (i.e. it is I2-like) [16]; this form slowly aggregates and 
precipitates [7,10]. R-cam--lactalbumin also has an I2-like structure (Table 1) but, 
unlike reduced -lactalbumin, is stable in solution as a monomeric species and does 
not interact with clusterin. Clearly, the marked variation between the two -
lactalbumin species in their affinity for clusterin cannot be explained on the basis of 
gross differences in structure. However, there must be subtle structural differences 
which, in the case of reduced -lactalbumin, mean a greater exposure of 
hydrophobicity to solution and a consequent tendency for it to undergo large-scale, 
ill-defined aggregation [21]. Clusterin exists as a heterogeneous aggregate and 
undergoes subunit exchange [22], a process similar to that undergone by reduced -
lactalbumin monomers which are continuously exchanging during their aggregation 
to form species of a very broad mass range [21]. Thus, the similar dynamic and 
heterogeneously aggregated nature of clusterin and reduced -lactalbumin may 
facilitate their mutual incorporation into a complex during chaperone interaction. 
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There are two phases to the interaction between -crystallin and the I2 state of 
reduced -lactalbumin. Firstly, I2 is significantly stabilised and aggregation is 
prevented, probably via transient interactions between the monomeric I2 state and -
crystallin. Secondly, I2 stably binds to -crystallin to form a complex of large mass 
[10,11]. ther mammalian sHsps and plant sHsps behave in the same manner during 
their interaction with reduced -lactalbumin [10,11, J.A. Carver, R.A. Lindner, M. 
Gaestel, E. Basha, and E. Vierling, unpublished results]. Our results suggest that 
clusterin interacts with the I2 state of -lactalbumin by a similar two-stage 
mechanism. Firstly, real time NMR analysis showed that, during reductive stress, 
clusterin extended the lifetime of the I2 state of -lactalbumin about three-fold (Figure 
2C). This indicates that clusterin stabilised the non-aggregated (probably monomeric) 
form of this intermediate. Secondly, the demonstration that clusterin forms a high-
molecular-mass complex with reduced -lactalbumin [7] suggests that it, like -
crystallin, preferentially complexes with an unstable, intermediately folded state of -
lactalbumin. Furthermore, the progressive loss of the NMR spectrum of the I2 state of 
-lactalbumin during reduction in the presence of clusterin is consistent with the 
formation of a high-molecular-mass -lactalbumin-clusterin complex. A broad range 
of other target proteins that have been stressed by either reduction or heating also 
form complexes with clusterin [7,9].  
 
The aggregation and precipitation of reduced -lactalbumin occurs relatively slowly. 
The ability of clusterin to interact efficiently with this form of -lactalbumin and 
prevent its precipitation suggested that kinetic factors might be important in 
regulating the efficiency of clusterin chaperone action. To examine this hypothesis, 
we tested the relative ability of clusterin to inhibit (i) the slow precipitation of -
crystallin and lysozyme (induced by heat and reduction, respectively), versus (ii) the 
rapid precipitation of the same proteins induced by dilution from denaturant. Under 
both conditions, the proteins unfold to adopt partly structured intermediates. 
Experimentally, it has been shown that under dilute conditions, the major -crystallin 
subunit, B, and lysozyme both form partly folded intermediates in the presence of 
denaturant and when diluted from denaturant [23,24]. B-crystallin at pH 2.0 and in 
3M urea forms an intermediate that has an unfolded C-terminal domain and a folded 
N-terminal domain [23]. When lysozyme is diluted from denaturant, an intermediate 
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rapidly forms that has tyrosine residues, but not tryptophan residues, exposed to 
solvent [24]. This intermediate then rearranges with a t1/2 of 350 ms to form the native 
state in which the tyrosine residues become buried but two tryptophan residues 
become exposed to solvent. It is likely that these intermediates of B-crystallin and 
lysozyme resemble those present in our studies in which high concentrations of these 
proteins were rapidly diluted from solutions containing denaturant, resulting in their 
rapid aggregation and precipitation. The results herein demonstrate that clusterin 
efficiently inhibits the slow precipitation of -crystallin and lysozyme induced by heat 
or reduction, but is incapable of preventing the rapid precipitation of the same 
proteins induced by dilution from denaturant (Figure 3). Thus, the findings support 
the hypothesis that kinetic factors are important in the chaperone action of clusterin 
and suggest that it is unable to efficiently inhibit rapid protein precipitation. 
 
In contrast to GroEL [15,16], the sHsps have no affinity for stable, partly folded 
intermediate states of -lactalbumin, or unstable intermediate states of proteins that 
aggregate and precipitate very rapidly [10,18,26]. The sHsps only bind to long-lived, 
intermediate states of proteins that slowly aggregate as they progress along their off-
folding pathway [10,11]. Furthermore, unlike Hsp60 and Hsp70, sHsps do not affect 
the rate of folding of proteins (e.g. -lactalbumin) when they progress via a series of 
transient intermediates along a folding pathway from their unfolded to folded form 
[18,26, J.A. Carver, R.A. Lindner, C. Lyon, D. Canet, H. Hernandez, C.M. Dobson 
and C. Redfield, submitted for publication]. Collectively, our results suggest that 
clusterin shares all of these features with the sHsps. Furthermore, for -lactalbumin, 
our results indicate that during reductive stress, like -crystallin and other sHsps, 
clusterin stabilises the I2 state of -lactalbumin. Figure 4 summarises the steps in the 
chaperone action of clusterin with reduced -lactalbumin.  
 
In conclusion, the above data support the hypothesis that clusterin does not interact in 
a chaperone role with stable, non-aggregating intermediate states of proteins or those 
that are present when proteins undergo very rapid aggregation and precipitation. 
Furthermore, we recently demonstrated that clusterin does not affect the heat-induced 
loss of activity of glutathione-S-transferase or alcohol dehydrogenase or, when acting 
alone, promote the refolding of these proteins to regain function following the 
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removal of heat stress [9]. Thus, it appears likely that clusterin does not interact with 
proteins along their folding/unfolding pathway, a process that occurs relatively 
rapidly. Instead, clusterin prefers slowly aggregating, long lived and precipitation-
bound intermediate states of proteins that are present on an irreversible, off-folding 
pathway (Figure 4). Clusterin complexes to these and thereby prevents their 
precipitation. Therefore, the efficiency of the chaperone action of clusterin, like that 
of the sHsps [10,11,26], is dependent on both conformational and kinetic factors.  
 
Clusterin expression is increased in diseases characterised by protein misfolding, 
aggregation and precipitation, for example, in Alzheimer’s and Creutzfeldt-Jakob 
diseases [27]. In these diseases, fibrous protein precipitates known as amyloid or 
plaque slowly form in extracellular spaces [3]. It is believed that amyloid formation 
occurs via the association of destabilised, intermediately folded states of proteins 
[28]. The observations that clusterin is an extracellular chaperone [8] and that it 
interacts with these forms of proteins (results presented here), suggest that it may 
influence the development of amyloid diseases. Indeed, Oda et al. [29] demonstrated 
that clusterin inhibited the formation of large insoluble fibrils resulting from the 
aggregation of amyloid -peptide, the putative causative agent in Alzheimer’s 
disease. However, the pathogenicity of the resultant mixture towards neuronal cells 
was enhanced, suggesting that the smaller fibrils formed in the presence of clusterin 
are the pathogenic species. Similar effects were reported for the interaction of sHsps 
with the amyloid -peptide [30,31]. The association of clusterin with Alzheimer’s 
plaques in vivo [27] may reflect the inability of clusterin to completely inhibit the 
large-scale precipitation of amyloid -peptide under pathogenic conditions. To 
examine the potential role of clusterin in amyloid diseases, we are currently testing its 
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Table 1.  Modifications and structural features of -lactalbumin derivatives 




Modifications Structural features 
 R-cam--
lactalbumin 
Four disulphide bonds 
reduced and subsequently 
blocked by carboxyamidation 
Disordered conformation, 
with some secondary 
structure but no tertiary 
structure [10,13,16] (I2-like)
 R-cm--lactalbumin Four disulphide bonds 





 3SS--lactalbumin Cys6-Cys120 selectively 
reduced in the presence of 
EDTA and blocked by 
carboxymethylation 
Relatively folded 
conformation with most 
secondary and some tertiary 
structure. Similar in 
conformation to heated apo-
-lactalbumin [10,13,14,16] 
(I1-like)
 apo--lactalbumin Heated at 45 oC in the 
presence of EDTA to remove 
bound Ca2+ 
Ordered conformation with 
most secondary structure and 
some tertiary structure. 





Reduced by incubation with 
20 mM DTT at 37oC  
Similar to R-cam--
lactalbumin (I2-like) with the 
exception that, unlike R-cam-
-lactalbumin, this form is 
unstable in solution and 






Figure 1. (A) Binding of clusterin to derivatives of -lactalbumin in ELISA. Results 
of ELISA testing the binding of clusterin to various structural forms of -lactalbumin. 
As controls, ELISA plates were also coated with reduced (DTT-treated) -
lactalbumin to which clusterin binds [7]. The results shown are representative of 
several independent experiments. In each case, the error bars shown are standard 
errors (SE) of the mean of triplicate measurements. In some cases, the SE are too 
small to be visible. (B) Native gel electrophoresis of mixtures of clusterin and various 
forms of -lactalbumin. Clusterin, or mixtures of clusterin with various forms of -
lactalbumin, were stressed as described in the Experimental section or left untreated 
before subjecting the proteins to native gel electrophoresis. The image shows a native 
gel following electrophoresis and protein staining. The key to the right of the image 
indicates the identity of proteins or protein mixtures loaded into each lane. The arrow 
indicates, in lane 6, a band of unique electrophoretic mobility corresponding to a 
clusterin--lactalbumin complex (see text). The results shown are representative of 
three independent experiments. Note that there are no protein bands visible in lane 4 
because reduced -lactalbumin precipitates from solution. 
 
Figure 2. Real-time 1H NMR spectroscopy and kinetics of the reduction of -
lactalbumin in the absence and presence of clusterin. 
Aromatic region of the 1H NMR spectra of -lactalbumin at the times indicated after 
the addition of DTT. (A) -Lactalbumin only; (B) 4.3:1.0 w:w -
lactalbumin:clusterin. Representative results are shown. (C) Plots showing the 
resonance intensity of the -lactalbumin tyrosine (3,5) aromatic protons (at 6.8 ppm) 
as a function of time during reduction; -Lactalbumin only (); 4.3:1.0 w:w -
lactalbumin:clusterin ().  
 
Figure 3. The effect of clusterin on the slow and rapid precipitation of -crystallin 
and lysozyme  
Slow precipitation: (A) -Crystallin (1 mg/ml in 50 mM Na2HPO4, pH 7.0) was 
heated at 60 oC in the presence () or absence () of clusterin (50 g/ml). (B) 
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Lysozyme (250 g/ml) was reduced at 42 oC with 20 mM DTT in the presence () or 
absence () of clusterin (400 g/ml). The data points shown in (A) and (B) each 
represent the mean of triplicate measurements; the SE of the means are too small to 
be visible. Rapid precipitation: (C) 300 g of 6 M GuHCl-denatured -crystallin (see 
Materials and Methods) was rapidly precipitated following a 10-fold dilution with 50 
mM Na2HPO4 buffer, pH 7.0, in the presence of 15 g of either clusterin (solid bar), 
BSA (shaded bar) or ovotransferrin (striped bar). (D) 100 g of 6 M GuHCl-
denatured lysozyme was rapidly precipitated following a 5-fold dilution with 50 mM 
Na2HPO4 buffer, pH 7.0, in the presence of 160 g of either clusterin (solid bar), 
BSA (shaded bar) or ovotransferrin (striped bar). In (A) to (D), protein precipitation 
(turbidity) was measured as light scattering at 360 nm (A360). In (C) and (D), only end 
point precipitation was measured and error bars shown are standard errors of the 
mean of triplicate measurements in each case; none of the proteins added had a 
significant effect on the extent of rapid precipitation of either -crystallin or lysozyme 
(p>0.05, t-test). The results shown are representative of three independent 
experiments. 
 
Figure 4. A proposed mechanism for the chaperone interaction of clusterin with 
reduced -lactalbumin. 
I1 and I2 represent, respectively, more structured and less structured, partly folded 
intermediates of -lactalbumin. Thus, I1 is characterised by having most secondary 
structure in place and some elements of tertiary structure, whereas I2 has some 
elements of secondary structure but little or no tertiary structure. Under reducing 
conditions, the I2 species is long lived and is prone to entering the slow and 
irreversible off-folding pathway leading to aggregation and precipitation. It is this 
species that clusterin recognises, stabilises (probably via transient interactions with 










































              Lane: 1 = Unstressed clusterin	

                      2 = Reduced clusterin	

                      3 = Unstressed α-lactalbumin	

                      4 = Reduced α-lactalbumin	

                      5 = Unstressed clusterin + α-lactalbumin	

                      6 = Reduced (clusterin + α-lactalbumin) (complex)	

                      7 = Apo α-lactalbumin	

                      8 = Apo α-lactalbumin + clusterin	

                      9 = CAM-α-lactalbumin	

                    10 = CAM-α-lactalbumin + clusterin	

                    11 = CM-α-lactalbumin	

                    12 = CM-α-lactalbumin + clusterin	

                    13 = 3SS-α-lactalbumin	

                    14 = 3SS-α-lactalbumin + clusterin	
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